ARAY Stock Analysis: Buy, Sell, or Hold?
ARAY - Accuray Incorporated
$0.28
-0.01 (-3.90%)
âŧ
5d:
+1.01%
30d:
+17.97%
90d:
-8.35%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 19, 2026
0d
Get Alerted When ARAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ARAY is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ARAY is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: ARAY is currently trading at $0.28, which is considered slightly high relative to its 30-day fair value range of $0.25 to $0.30. From a valuation perspective, the stock is trading at a discount (Forward PE: -0.9) compared to its historical average (39.3). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, ARAY is in a strong downtrend. Immediate support is located at $0.26, while resistance sits at $0.34. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: ARAY scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $0.35 (+24.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARAY is in a strong downtrend. Immediate support is located at $0.26, while resistance sits at $0.34. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: ARAY scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $0.35 (+24.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.25 -
$0.30
Company Quality Score
40/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
38.1%
Protect Your Profits
Holding ARAY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Weak technical setup (38/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
- BULLISH: Trading 24.6% below Wall St target ($0.35)
- WARNING: Composite score 40/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.25 -
$0.30
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.26
Resistance Level
$0.34
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.94
Wall Street Target
$0.35
(+24.6%)
Revenue Growth (YoY)
-7.4%
Earnings Growth (YoY)
-96.2%
Profit Margin
-10.8%
PE vs Historical
-0.9 vs 39.3
CHEAP
Share & Embed Analysis
Last updated: August 24, 2026 2:51 AM ET
Data refreshes hourly during market hours. Next update: 3:50 AM
Data refreshes hourly during market hours. Next update: 3:50 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 31 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 37 SELL |
Advanced ARAY Option Strategies
Professional options setups generated by AI based on today's ARAY price and gamma walls.
